Short interest in Y-mAbs Therapeutics Inc (NASDAQ:YMAB) increased during the last reporting period, rising from 3.63M to 3.84M. This put 10.28% of the company's publicly available shares short.

Short interest for Y-mAbs Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Y-mAbs Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 231.98K shares traded per day, it would take 16.55 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.